Free Trial

Mirum Pharmaceuticals (MIRM) Competitors

Mirum Pharmaceuticals logo
$74.42 -1.77 (-2.32%)
Closing price 04:00 PM Eastern
Extended Trading
$74.42 +0.00 (+0.01%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MIRM vs. ASND, RDY, VTRS, ROIV, BBIO, MRNA, QGEN, ELAN, VRNA, and RVMD

Should you be buying Mirum Pharmaceuticals stock or one of its competitors? The main competitors of Mirum Pharmaceuticals include Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Roivant Sciences (ROIV), BridgeBio Pharma (BBIO), Moderna (MRNA), QIAGEN (QGEN), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry.

Mirum Pharmaceuticals vs. Its Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk.

Ascendis Pharma A/S has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Mirum Pharmaceuticals has a net margin of -13.65% compared to Ascendis Pharma A/S's net margin of -54.94%. Ascendis Pharma A/S's return on equity of 0.00% beat Mirum Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Ascendis Pharma A/S-54.94% N/A -24.31%
Mirum Pharmaceuticals -13.65%-24.76%-8.50%

Mirum Pharmaceuticals has higher revenue and earnings than Ascendis Pharma A/S. Mirum Pharmaceuticals is trading at a lower price-to-earnings ratio than Ascendis Pharma A/S, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ascendis Pharma A/S$393.54M32.45-$409.12M-$5.16-40.12
Mirum Pharmaceuticals$429.16M8.71-$87.94M-$1.21-61.50

In the previous week, Ascendis Pharma A/S had 1 more articles in the media than Mirum Pharmaceuticals. MarketBeat recorded 14 mentions for Ascendis Pharma A/S and 13 mentions for Mirum Pharmaceuticals. Mirum Pharmaceuticals' average media sentiment score of 0.82 beat Ascendis Pharma A/S's score of 0.61 indicating that Mirum Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ascendis Pharma A/S
6 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Mirum Pharmaceuticals
4 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ascendis Pharma A/S currently has a consensus target price of $248.29, indicating a potential upside of 19.93%. Mirum Pharmaceuticals has a consensus target price of $76.91, indicating a potential upside of 3.34%. Given Ascendis Pharma A/S's higher possible upside, equities analysts clearly believe Ascendis Pharma A/S is more favorable than Mirum Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ascendis Pharma A/S
1 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.88
Mirum Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
3.00

Summary

Mirum Pharmaceuticals beats Ascendis Pharma A/S on 9 of the 15 factors compared between the two stocks.

Get Mirum Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MIRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MIRM vs. The Competition

MetricMirum PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$3.74B$3.38B$6.13B$10.46B
Dividend YieldN/A2.30%5.73%4.78%
P/E Ratio-61.5022.9185.0627.23
Price / Sales8.71439.69573.27177.38
Price / CashN/A46.1137.3961.86
Price / Book15.8310.4812.386.64
Net Income-$87.94M-$52.47M$3.32B$276.79M
7 Day Performance0.81%-1.06%-0.27%-1.54%
1 Month Performance0.85%14.40%9.52%5.44%
1 Year Performance87.08%13.86%71.62%36.30%

Mirum Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MIRM
Mirum Pharmaceuticals
3.2175 of 5 stars
$74.42
-2.3%
$76.91
+3.3%
+91.9%$3.74B$429.16M-61.50140Analyst Forecast
Analyst Revision
ASND
Ascendis Pharma A/S
3.105 of 5 stars
$208.43
-0.5%
$248.29
+19.1%
+62.7%$12.93B$393.54M-40.391,017News Coverage
Analyst Forecast
Analyst Revision
Gap Up
RDY
Dr. Reddy's Laboratories
2.828 of 5 stars
$14.36
+0.1%
$16.95
+18.1%
-11.0%$11.97B$3.81B21.7527,811News Coverage
VTRS
Viatris
2.2316 of 5 stars
$9.86
+1.2%
$10.40
+5.5%
-15.7%$11.36B$14.74B-3.4032,000News Coverage
Analyst Forecast
ROIV
Roivant Sciences
3.0242 of 5 stars
$16.21
+1.1%
$19.94
+23.0%
+43.0%$10.95B$29.05M-23.16860Insider Trade
BBIO
BridgeBio Pharma
4.3037 of 5 stars
$55.96
+0.8%
$63.94
+14.3%
+123.1%$10.61B$221.90M-13.68400Analyst Revision
MRNA
Moderna
4.2566 of 5 stars
$26.74
-0.3%
$41.81
+56.4%
-51.6%$10.48B$3.24B-3.555,800
QGEN
QIAGEN
4.2586 of 5 stars
$47.30
+1.0%
$49.40
+4.4%
+11.5%$10.41B$1.98B27.955,765
ELAN
Elanco Animal Health
2.7807 of 5 stars
$20.04
+1.4%
$19.14
-4.5%
+47.1%$9.82B$4.44B23.309,000Analyst Revision
VRNA
Verona Pharma PLC American Depositary Share
1.4602 of 5 stars
$106.91
flat
$109.00
+2.0%
N/A$9.21B$42.28M-107.9930Positive News
RVMD
Revolution Medicines
4.2591 of 5 stars
$48.75
+1.1%
$74.64
+53.1%
+1.2%$9.02B$11.58M-10.83250Analyst Forecast
Insider Trade

Related Companies and Tools


This page (NASDAQ:MIRM) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners